SCHEMBL10073602

SCHEMBL10073602

CC=C(Cc1cccc(Cl)c1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTBP2 P56545 2/20 0.59
HTR3E A5X5Y0 1/20 0.49
HTR3B O95264 1/20 0.49
HTR3A P46098 1/20 0.49
HTR3D Q70Z44 1/20 0.49
HTR3C Q8WXA8 1/20 0.49
PIK3CA P42336 1/20 0.48
ALDH1A1 P00352 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HCAR2 Q8TDS4 1/20 0.47
EPHX2 P34913 1/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
KCNQ2 O43526 1/20 0.45
TAAR1 Q96RJ0 1/20 0.44
ATM Q13315 1/20 0.44
RXRA P19793 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12516012 0.81 CTBP2 (0.59) CTBP2ALDH1A1CYP3A4CYP2C9TAAR1
SCHEMBL12516017 0.80 HCAR2 (0.47) MEN1KMT2AHCAR2CYP3A4CYP2C9
SCHEMBL265774 0.80 CYP3A4 (0.66) CTBP2ALDH1A1MEN1KMT2AHPGD
SCHEMBL367454 0.80 CYP3A4 (0.66) CTBP2ALDH1A1MEN1KMT2AHPGD
SCHEMBL7923429 0.80 CYP3A4 (0.66) CTBP2ALDH1A1MEN1KMT2AHPGD
SCHEMBL5790565 0.79 CTBP2 (0.67) CTBP2HTR3EHTR3BHTR3AHTR3D
SCHEMBL10073603 0.79 CTBP2 (0.53) CTBP2PIK3CAALDH1A1MEN1KMT2A
SCHEMBL467923 0.78 CTBP2 (0.66) CTBP2HTR3EHTR3BHTR3AHTR3D
Hydrochloric Acid SCHEMBL2531827 0.77 CTBP2 (0.64) CTBP2HTR3EHTR3BHTR3AHTR3D
Ammonia Solution, Strong SCHEMBL5702482 0.77 CTBP2 (0.64) CTBP2HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB CTBP2 2175/4885HTR3E 4726/4885HTR3B 4740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.